Patterson Companies (PDCO) Competitors

$25.76
-0.09 (-0.35%)
(As of 05/17/2024 ET)

PDCO vs. OMI, APGE, MYGN, AGL, ASTH, CNMD, RXST, VERA, RXRX, and VCEL

Should you be buying Patterson Companies stock or one of its competitors? The main competitors of Patterson Companies include Owens & Minor (OMI), Apogee Therapeutics (APGE), Myriad Genetics (MYGN), agilon health (AGL), Astrana Health (ASTH), CONMED (CNMD), RxSight (RXST), Vera Therapeutics (VERA), Recursion Pharmaceuticals (RXRX), and Vericel (VCEL). These companies are all part of the "medical" sector.

Patterson Companies vs.

Owens & Minor (NYSE:OMI) and Patterson Companies (NASDAQ:PDCO) are both medical companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, institutional ownership, community ranking, valuation, profitability, risk, earnings, dividends and media sentiment.

Owens & Minor has a beta of 0.52, meaning that its share price is 48% less volatile than the S&P 500. Comparatively, Patterson Companies has a beta of 1.07, meaning that its share price is 7% more volatile than the S&P 500.

98.0% of Owens & Minor shares are owned by institutional investors. Comparatively, 85.4% of Patterson Companies shares are owned by institutional investors. 3.6% of Owens & Minor shares are owned by company insiders. Comparatively, 1.5% of Patterson Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Patterson Companies received 110 more outperform votes than Owens & Minor when rated by MarketBeat users. Likewise, 52.48% of users gave Patterson Companies an outperform vote while only 48.64% of users gave Owens & Minor an outperform vote.

CompanyUnderperformOutperform
Owens & MinorOutperform Votes
250
48.64%
Underperform Votes
264
51.36%
Patterson CompaniesOutperform Votes
360
52.48%
Underperform Votes
326
47.52%

Patterson Companies has lower revenue, but higher earnings than Owens & Minor. Owens & Minor is trading at a lower price-to-earnings ratio than Patterson Companies, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Owens & Minor$10.33B0.14-$41.30M-$0.51-36.51
Patterson Companies$6.47B0.36$207.56M$2.0312.69

In the previous week, Owens & Minor had 1 more articles in the media than Patterson Companies. MarketBeat recorded 8 mentions for Owens & Minor and 7 mentions for Patterson Companies. Patterson Companies' average media sentiment score of 0.22 beat Owens & Minor's score of 0.10 indicating that Owens & Minor is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Owens & Minor
1 Very Positive mention(s)
2 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
1 Very Negative mention(s)
Neutral
Patterson Companies
1 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
1 Negative mention(s)
1 Very Negative mention(s)
Neutral

Owens & Minor presently has a consensus price target of $23.29, indicating a potential upside of 25.06%. Patterson Companies has a consensus price target of $32.56, indicating a potential upside of 26.38%. Given Owens & Minor's stronger consensus rating and higher probable upside, analysts plainly believe Patterson Companies is more favorable than Owens & Minor.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Owens & Minor
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00
Patterson Companies
0 Sell rating(s)
6 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Patterson Companies has a net margin of 2.95% compared to Patterson Companies' net margin of -0.37%. Owens & Minor's return on equity of 20.98% beat Patterson Companies' return on equity.

Company Net Margins Return on Equity Return on Assets
Owens & Minor-0.37% 12.97% 2.26%
Patterson Companies 2.95%20.98%7.70%

Summary

Patterson Companies beats Owens & Minor on 13 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PDCO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PDCO vs. The Competition

MetricPatterson CompaniesMedical & hospital equipment IndustryMedical SectorNASDAQ Exchange
Market Cap$2.31B$7.85B$5.24B$7.99B
Dividend Yield4.04%2.33%44.24%3.91%
P/E Ratio12.6919.0594.4914.25
Price / Sales0.361.172,373.7280.89
Price / Cash7.8611.1836.7931.98
Price / Book2.252.325.494.64
Net Income$207.56M$249.27M$105.95M$217.28M
7 Day Performance1.82%1.71%1.42%2.90%
1 Month Performance-1.00%-3.66%4.96%6.66%
1 Year Performance-4.56%0.06%7.84%9.89%

Patterson Companies Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
OMI
Owens & Minor
4.8098 of 5 stars
$19.77
+5.7%
$23.29
+17.8%
-7.5%$1.51B$10.33B-38.7613,700Analyst Upgrade
APGE
Apogee Therapeutics
2.9205 of 5 stars
$54.00
+2.4%
$73.00
+35.2%
N/A$2.26BN/A0.0091Short Interest ↑
Analyst Revision
News Coverage
High Trading Volume
MYGN
Myriad Genetics
1.9726 of 5 stars
$25.36
+1.7%
$25.57
+0.8%
+34.7%$2.30B$753.20M-8.992,700Insider Selling
AGL
agilon health
1.8418 of 5 stars
$5.50
+5.6%
$9.32
+69.5%
-76.1%$2.26B$4.32B-7.861,117
ASTH
Astrana Health
2.2484 of 5 stars
$40.02
+2.2%
$46.33
+15.8%
N/A$2.24B$1.39B30.321,800
CNMD
CONMED
4.9926 of 5 stars
$72.47
-0.5%
$107.86
+48.8%
-37.2%$2.23B$1.24B27.774,000Short Interest ↓
RXST
RxSight
2.039 of 5 stars
$60.21
+2.4%
$60.63
+0.7%
+147.3%$2.23B$89.08M-47.79374Positive News
VERA
Vera Therapeutics
0.5984 of 5 stars
$40.87
+0.3%
$36.71
-10.2%
+459.3%$2.23BN/A-19.9451Positive News
RXRX
Recursion Pharmaceuticals
1.9828 of 5 stars
$10.05
+6.0%
$12.75
+26.9%
+72.2%$2.36B$44.58M-6.28500Gap Up
VCEL
Vericel
0.6164 of 5 stars
$48.53
+0.0%
$46.80
-3.6%
+46.7%$2.36B$197.52M-4,848.15314Analyst Upgrade

Related Companies and Tools

This page (NASDAQ:PDCO) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners